Gao Hanlin 4
4 · Fulgent Genetics, Inc. · Filed Jan 28, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) CSO Gao Hanlin — Shares Withheld for Taxes
What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), had 1,331 shares withheld on January 26, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units. The shares were valued at $27.53 each, totaling $36,642. This was a tax-withholding disposition (code F), not an open-market sale or purchase.
Key Details
- Transaction date: January 26, 2026; filing date: January 28, 2026 (timely Form 4 filing).
- Shares withheld/disposed: 1,331 at $27.53 per share; total value $36,642.
- Transaction code: F — shares withheld to satisfy tax withholding on vested RSUs.
- Footnote: These RSUs were assumed under the Merger Agreement dated November 7, 2022 and were originally reported on a Form 4 filed November 9, 2022.
- Shares owned after the transaction: not specified in the excerpt provided.
Context Withholding shares to cover taxes on vested RSUs is a routine administrative event and does not necessarily indicate the insider is selling additional shares or expressing a view on the company's prospects. The transaction reflects tax obligations triggered by vesting rather than an investment decision.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-01-26$27.53/sh−1,331$36,642→ 951,559 total
Footnotes (1)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.